• Visit the USI website
  • Go back to the homepage

Institute for Research in Biomedicine
Istituto di Ricerca in Biomedicina

Via Vincenzo Vela 6 - CH-6500 Bellinzona
Tel. +41 91 820 0300 - Fax +41 91 820 0302 - info [at] irb [dot] usi [dot] ch

Jessica Marcandalli, MSc

Technician

Via Vela, 6
6500 Bellinzona, Switzerland

Projects
Structure Based Nanoparticle Vaccine Design
HCMV Envelope Glycoprotein Diversity
Vaccine for Respiratory Syncytial Virus using Designed Protein Nanoparticle
Neuropilin-2 is a Central Viral Receptor for Human Cytomegalovirus
Publications
HCMV Envelope Glycoprotein Diversity Demystified
M. Foglierini, J. Marcandalli, L. Perez
in Front Microbiol (2019) vol. 10 pp1005
Induction of Potent Neutralizing Antibody Responses by a Designed Protein Nanoparticle Vaccine for Respiratory Syncytial Virus
J. Marcandalli, B. Fiala, S. Ols, M. Perotti, W. de van der Schueren, J. Snijder, E. Hodge, M. Benhaim, R. Ravichandran, L. Carter, W. Sheffler, L. Brunner, M. Lawrenz, P. Dubois, A. Lanzavecchia, F. Sallusto, K. K. Lee, D. Veesler, C. E. Correnti, L. J. Stewart, D. Baker, K. Lore, L. Perez, N. P. King
in Cell (2019) vol. 176 pp1420-1431 e17
* J. Marcandalli and B. Fiala contributed equally to this work. L. Perez and N. P. King contributed equally to this work and are co-corresponding authors.
An Unbiased Screen for Human Cytomegalovirus Identifies Neuropilin-2 as a Central Viral Receptor
N. Martinez-Martin, J. Marcandalli, C. S. Huang, C. P. Arthur, M. Perotti, M. Foglierini, H. Ho, A. M. Dosey, S. Shriver, J. Payandeh, A. Leitner, A. Lanzavecchia, L. Perez, C. Ciferri
in Cell (2018) vol. 174 pp1158-1171
* L. Perez and C. Ciferri contributed equally; N M-M, LP and CC are co-corresponding authors
A public antibody lineage that potently inhibits malaria infection through dual binding to the circumsporozoite protein
J. Tan, B. K. Sack, D. Oyen, I. Zenklusen, L. Piccoli, S. Barbieri, M. Foglierini, C. S. Fregni, J. Marcandalli, S. Jongo, S. Abdulla, L. Perez, G. Corradin, L. Varani, F. Sallusto, B. K. L. Sim, S. L. Hoffman, S. H. I. Kappe, C. Daubenberger, I. A. Wilson, A. Lanzavecchia
in Nat Med (2018) vol. 24 pp401-407
* Tan J., Sack B. K., Oyen D., Zenklusen I., Piccoli L. contributed equally to this work.
Platelet-derived growth factor-alpha receptor is the cellular receptor for human cytomegalovirus gHgLgO trimer
A. Kabanova, J. Marcandalli, T. Zhou, S. Bianchi, U. Baxa, Y. Tsybovsky, D. Lilleri, C. Silacci-Fregni, M. Foglierini, B. M. Fernandez-Rodriguez, A. Druz, B. Zhang, R. Geiger, M. Pagani, F. Sallusto, P. D. Kwong, D. Corti, A. Lanzavecchia, L. Perez
in Nat Microbiol (2016) vol. 1 pp16082
Anna Kabanova, Jessica Marcandalli, Tongqing Zhou equally contributed to this work; Antonio Lanzavecchia1and Laurent Perez jointly supervised this work.
Antibody-driven design of a human cytomegalovirus gHgLpUL128L subunit vaccine that selectively elicits potent neutralizing antibodies
A. Kabanova, L. Perez, D. Lilleri, J. Marcandalli, G. Agatic, S. Becattini, S. Preite, D. Fuschillo, E. Percivalle, F. Sallusto, G. Gerna, D. Corti, A. Lanzavecchia
in Proc Natl Acad Sci U S A (2014) vol. 111 pp17965-70
A.K. and L.P. contributed equally to this work.
Cross-neutralization of four paramyxoviruses by a human monoclonal antibody
D. Corti, S. Bianchi, F. Vanzetta, A. Minola, L. Perez, G. Agatic, B. Guarino, C. Silacci, J. Marcandalli, B. J. Marsland, A. Piralla, E. Percivalle, F. Sallusto, F. Baldanti, A. Lanzavecchia
in Nature (2013) vol. 501 pp439-43
Purinergic P2X7 Receptor Drives T Cell Lineage Choice and Shapes Peripheral gammadelta Cells
M. Frascoli, J. Marcandalli, U. Schenk, F. Grassi
in J Immunol (2012) vol. 189 pp174-80